By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131




Metabasis Therapeutics, Inc.  – Hepatitis B

Company News
Commonweath Laboratories Announces Agreement With Valeant (VRX) For The Acquisition Of Commonwealth’s U.S. And Canadian Business 7/23/2015 1:15:19 PM
Valeant (VRX) Reports Second Quarter 2015 Financial Results 7/23/2015 11:18:20 AM
Serial Acquirer Valeant (VRX) Buys Egyptian Amoun for $800 Million 7/17/2015 6:23:17 AM
Valeant (VRX) Spree Continues With $28 Million Buy 7/13/2015 7:22:50 AM
EyeGate Pharma Signs Licensing Agreement With Valeant (VRX) For EGP-437 Combination Product In Uveitis 7/10/2015 6:59:38 AM
No Worries, Bayer (BAY) Snubs Zoetis (ZTS) But Valeant (VRX) Still Looking 7/2/2015 6:28:17 AM
Valeant (VRX) Reportedly Makes Bid for Zoetis (ZTS) in "Mega Deal" 6/26/2015 7:21:20 AM
Valeant (VRX) To Announce 2015 Second Quarter Results On July 23, 2015 6/24/2015 10:38:11 AM
Valeant (VRX) and Progenics Pharmaceuticals, Inc. (PGNX) Announce the Submission of U.S. New Drug Application for Oral RELISTOR 6/23/2015 7:44:15 AM
Valeant (VRX) Taps M&A Expert as New CFO As Dealmaking Roars 6/11/2015 7:28:28 AM